スマートピルの市場規模、シェア、成長分析、対象領域別、用途別、適応疾患別、エンドユーザー別、地域別 - 産業予測 2025-2032年

スマートピル市場規模は2023年に10億米ドルと評価され、予測期間（2025-2032年）のCAGRは11.3%で、2024年の11億1,000万米ドルから2032年には26億2,000万米ドルに成長する見通しです。

スマートピル市場は、厳格な服薬アドヒアランスを必要とする心臓病、糖尿病、呼吸器疾患などの慢性疾患の有病率の上昇に牽引され、大きな成長を遂げています。コンプライアンス違反による患者の健康状態の悪化やヘルスケアコストの増加に直面しており、服薬管理におけるデジタル技術の統合が不可欠となっています。センサー、マイクロチップ、ワイヤレス通信を備えたスマートピルは、患者追跡機能を強化し、患者とヘルスケア専門家の間でリアルタイムのデータ共有を可能にします。さらに、有利な支払いモデル、低侵襲処置への嗜好の高まり、内視鏡検査の技術的進歩が市場を支えています。人工知能とスマートピル技術の相乗効果により、データ分析がさらに強化され、早期診断、治療精度、予防医療戦略が向上します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 特許分析
• 技術分析
• ケーススタディ
• 顧客と購買基準の分析

スマートピル市場規模：対象領域別& CAGR（2025-2032）

• 市場概要
• 小腸
• 大腸
• 食道
• 胃

スマートピル市場規模：用途別& CAGR（2025-2032）

• 市場概要
• カプセル内視鏡検査
• 患者モニタリング
• 標的ドラッグデリバリー

スマートピル市場規模：適応疾患別& CAGR（2025-2032）

• 市場概要
• 隠れた消化器官の出血
• クローン病
• 小腸腫瘍
• セリアック病
• その他の適応疾患

スマートピル市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 診断センター
• 外来診療所（クリニック、外来診療センター）
• その他のエンドユーザー

スマートピル市場規模& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Medtronic PLC（Ireland）
• Proteus Digital Health Inc.（US）
• CapsoVision Inc.（US）
• Olympus Corporation（Japan）
• Medisafe（US）
• Bio-Images Research Limited（UK）
• BodyCap（France）
• Philips Healthcare（Netherlands）
• Medimetrics Personalized Drug Delivery B.V.（Netherlands）
• PENTAX Medical（Japan）
• Proteus Biomedical（US）
• Check-Cap Ltd.（Israel）
• IntroMedic Co. Ltd.（South Korea）

結論と提言

Smart Pills Market size was valued at USD 1.0 billion in 2023 and is poised to grow from USD 1.11 billion in 2024 to USD 2.62 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

The smart pills market is experiencing significant growth, driven by the rising prevalence of chronic diseases like heart disease, diabetes, and respiratory issues, which necessitate stringent medication adherence. With patients facing poor health outcomes and increased healthcare costs due to non-compliance, the integration of digital technology in medication management has become essential. Smart pills, equipped with sensors, microchips, and wireless communication, enhance patient-tracking capabilities, allowing real-time data sharing between patients and healthcare professionals. Additionally, the market is supported by favorable payment models, a growing preference for minimally invasive procedures, and technological advancements in endoscopy. The synergy of artificial intelligence with smart pill technology is further enhancing data analytics, thus improving early diagnosis, treatment precision, and preventive care strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Pills market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Smart Pills Market Segments Analysis

Global Smart Pills Market is segmented by Target Area, Application, Disease Indication, End User and region. Based on Target Area, the market is segmented into Small Intestine, Large Intestine, Esophagus and Stomach. Based on Application, the market is segmented into Capsule Endoscopy, Patient Monitoring and Targeted Drug Delivery. Based on Disease Indication, the market is segmented into Occult Gi Bleeding, Crohn's Disease, Small Bowel Tumors, Celiac Disease and Other Disease Indications. Based on End User, the market is segmented into Hospitals, Diagnostic Centers, Outpatient Settings (Clinics, Ambulatory Care Centers) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Smart Pills Market

The integration of digital technologies in healthcare significantly drives the smart pills market. As the demand for patient-centered care and real-time health monitoring increases, smart medications emerge as innovative solutions that merge medication adherence with effective data tracking. These advanced medicines provide valuable degradation information, such as pH levels, temperature, and various physiological parameters, which can be transmitted directly to healthcare providers. This capability enables physicians to monitor patients more closely, enhance compliance, and minimize the risk of medication errors. The growing trend of personalized precision medicine is encouraging healthcare providers and clinicians to invest in and embrace smart pharmaceutical solutions, aligning with the overall shift toward digital health initiatives.

Restraints in the Smart Pills Market

Despite the numerous advantages offered by smart pills, their high price remains a significant obstacle to broader acceptance. The production of these advanced devices necessitates complex technology, including sensors, microchips, and wireless transmitters, which drive up manufacturing expenses. As a result, smart pills can become prohibitively expensive, particularly in low- and middle-income regions where healthcare resources are limited. Additionally, the absence of well-defined reimbursement frameworks for digital health innovations, such as smart pills, poses further difficulties for healthcare providers and insurance companies, hindering the integration of this innovative technology into mainstream healthcare solutions.

Market Trends of the Smart Pills Market

The Smart Pills market is witnessing a significant trend driven by advances in micro-sensor technology, enhancing the efficiency and capabilities of smart drugs. These modern tablets are equipped with miniature sensors that meticulously track vital gastrointestinal data, such as motility, acid levels, and real-time drug absorption metrics. This transformation positions smart pills as autonomous tools crucial for personalizing treatment and promoting behavioral development in patients. As healthcare trends lean toward more integrated and data-driven solutions, the demand for these innovative smart pills is expected to surge, offering immense potential for improved patient outcomes and streamlined healthcare delivery systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Technology Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Smart Pills Market Size by Target Area & CAGR (2025-2032)

• Market Overview
• Small Intestine
• Large Intestine
• Esophagus
• Stomach

Global Smart Pills Market Size by Application & CAGR (2025-2032)

• Market Overview
• Capsule Endoscopy
• Patient Monitoring
• Targeted Drug Delivery

Global Smart Pills Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Occult Gi Bleeding
• Crohn's Disease
• Small Bowel Tumors
• Celiac Disease
• Other Disease Indications

Global Smart Pills Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Outpatient Settings (Clinics, Ambulatory Care Centers)
• Other End Users

Global Smart Pills Market Size & CAGR (2025-2032)

• North America (Target Area, Application, Disease Indication, End User)
  • US
  • Canada
• Europe (Target Area, Application, Disease Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Target Area, Application, Disease Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Target Area, Application, Disease Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Target Area, Application, Disease Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteus Digital Health Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CapsoVision Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Images Research Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BodyCap (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medimetrics Personalized Drug Delivery B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PENTAX Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteus Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Check-Cap Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IntroMedic Co. Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations